627101-60-4

Upstream product

• 627101-58-0 propionic acid (1R,5R)-5-(tert-butyldimethyl-silanyloxy)-1-[(1S,2R,3S)-4-(3,4-dimethoxy-benzyloxy)-1,3-dimethyl-2-hydroxy-butyl]-(2E,6E,8E)-9-iodo-3-methyl-nona-2,6,8-trienyl ester 
• 627101-48-8 (6E,10E,12E)(2R,4R,5R,13R)-9-(tert-butyldimethyl-silanyloxy)-1-(3,4-dimethoxy-benzyloxy)-5-hydroxy-13-iodo-2,4,7-trimethyl-trideca-6,10,12-trien-3-one 
• 627101-55-7 methyl-(2E,5S,6E,8E)-5-(tert-butyldimethylsilyloxy)-9-iodo-3-methyl-2,6,8-nontrienoate 
• 627101-56-8 (2E,5S,6E,8E)-5-(tert-butyldimethylsilyloxy)-9-iodo-3-methyl-2,6,8-trien-1-ol 
• 627101-45-5 (2E,5S,6E,8E)-5-(tert-butyldimethylsilyloxy)-9-iodo-3-methyl-2,6,8-trienal 
• 627101-57-9 3-(3,4-dimethoxy-benzyloxy)-N-methoxy-2,N-dimethyl-propionamide 
• 627101-46-6 (R)-1-(3,4-Dimethoxy-benzyloxy)-2-methyl-pentan-3-one 
• 627101-47-7 methyl-(2E,5S,6E,8E)-5-hydroxy-9-iodo-3-methyl-2,6,8-nontrienoate 
• 212051-39-3 methyl 3-(3,4-dimethoxy-benzyloxy)-2-(R)-methyl-propionate 
• 168295-35-0 (2E,4E)-5-iodopenta-2,4-dienal 
• 905589-59-5 (3,4-dimethoxoxyphenyl)methyl 2,2,2-trichloroacetimidate 
• 79271-56-0 triethylsilyl trifluoromethyl sulfonate 
• 76927-59-8 (E)-((1-methoxy-3-methylbuta-1,3-dien-1-yl)oxy)trimethylsilane 
• 627101-59-1 propionic acid (1R,5R)-5-(tert-butyldimethyl-silanyloxy)-1-[(1R,2R,3R)-4-(3,4-dimethoxy-benzyloxy)-1,3-dimethyl-2-triethylsilanyloxy-butyl]-(2E,6E,8E)-9-iodo-3-methyl-nona-2,6,8-trienyl ester 

Downstream Products

• 627101-49-9 (6E,10E,12E)(2R,3S,4R,5R,9R)-9-(tert-butyldimethyl-silanyloxy)-1-(3,4-dimethoxy-benzyloxy)-13-iodo-5-methoxy-2,4,7-trimethyl-3-triethylsilanyloxy-trideca-6,10,12-triene 

Relevant academic research and scientific papers

Stereocontrolled Total Synthesis of (-)-Callipeltoside A

(Equation presented) A highly stereocontrolled total synthesis of the cytotoxic macrolide (-)-callipeltoside A has been achieved in 23 steps (4.8% overall). Notable features include a novel asymmetric vinylogous aldol reaction to install the C13 stereocen